In vitro activity of the orally bioavailable ceftibuten/VNRX-7145 (VNRX-5236 etzadroxil) combination against a challenge set of Enterobacterales pathogens carrying molecularly characterized β-lactamase genes

OBJECTIVES: This study assessed the activity of ceftibuten, ceftibuten combined with the active form (VNRX-5236) of the β-lactamase inhibitor VNRX-7145 and comparators against a challenge set of Gram-negative pathogens. METHODS: Two hundred and five Enterobacterales carrying plasmid AmpC (53 isolate...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Rodrigo E, Rhomberg, Paul R, Watters, Amy A, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865001/
https://www.ncbi.nlm.nih.gov/pubmed/34849977
http://dx.doi.org/10.1093/jac/dkab425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865001/
https://www.ncbi.nlm.nih.gov/pubmed/34849977
http://dx.doi.org/10.1093/jac/dkab425

Ejemplares similares